All Wrong About Alzheimer’s

STORY AT-A-GLANCE

  • Drug development for Alzheimer’s has so far been a dismal failure, with 300 failed trials to date
  • In a study of the experimental Alzheimer’s drugs gantenerumab and solanezumab, they failed to slow cognitive decline after an average of five years
  • The drugs were intended to remove beta-amyloid from the brain, but beta-amyloid is a symptom of Alzheimer’s — not the cause
  • Bredesen’s ReCODE protocol evaluates 150 factors, including biochemistry, genetics and historical imaging, known to contribute to Alzheimer’s disease
  • Bredesen has published a case report of 100 patients using the ReCODE protocol, in which all show sustained improvement in symptoms

Continue reading